National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1954. No..

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

Dated this  twenty-fourth

day of  June , 1954.

W. J. Slim

Governor-General.

By His Excellency’s Command,

SGD. EARLE PAGE

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations. 

Commencement.

1. These Regulations shall be deemed to have come into operation on the first day of June, 1954.

Interpretation.

2. Regulation 2 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting from the table in paragraph (b) of sub-regulation the letters and words—

“ BP British Pharmaceuticals Pty. Ltd.”; and

(b) by omitting from that table the letters and words—

“ OX	Oxo Limited
OP	Oppenheimer, Sons & Co. Ltd.”

and inserting in their stead the letters and words—

“ OP	Oppenheimer. Son & Co. Ltd.
OR	Organon Laboratories Ltd.
OX	Oxo Limited ”.

* Notified in the Commonwealth Gazette on , 1954.

  Statutory Rules 1954, No. 54.

2250.—Price 3d. 10/7.6.1954.

 

First Schedule.

3. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting item 2 and inserting in its stead the following item :—

 

“ 2	Adrenalin Hydrochloride, Solution of	1 in 1,000...................................	0.5 cc. amp.................................	DH, PD	6	1
1 in 1,000...................................		1 cc. amp....................................	DH, KL, PD	6	1
1 in 1,000...................................	10 cc. vial...................................	FA, PD	1	1
1 in 1,000...................................	1 fl. oz. bottle..............................	DH, FA, KL, PD, RT	1
1 in 1,000...................................	1 fl. oz. vial.................................	DH, RT	1
1 in 100......................................	6 cc. vial.....................................	PD	1	1
1 in 100......................................	10 cc. vial...................................	DH, FA	1	. .”;

(b) by omitting item 58 and inserting in its stead the following item :—

“ 58	Ephedrine Sulphate .................	½ gr. pre cc.................................	1 cc. amp....................................	AH	6	1
5% .............................................	1 cc. amp....................................	LY	6	1
3/8 gr...........................................	capsule ......................................	LY	40	1
¾ gr............................................	capsule ......................................	LY	40	1
½ gr............................................	hypo. tab.....................................	FA	20	1
¼ gr............................................	tablet ..........................................	HY, PD, RT	100	1
i	½ gr	tablet ..........................................	FS, HY, PD, RY	100	1” .

(c) by omitting item 83 and inserting in its stead the following item :—

“ 83	Insulin, Injection of ................	20 U. per cc................................	5 cc. vial.....................................	AH and BD, BW	3	12
20 U. per cc................................	10 cc. vial...................................	AH and BD, BW, GS	3	12
40 U. per cc................................	5 cc. vial.....................................	AH and BD, BT, BW	3	12
40 U. per cc................................	10 cc. vial...................................	AH and BD, BT. BW, CS	3	12
60 U. per cc................................	5 cc. vial.....................................	CS	3	12
80 U. per cc................................	5 cc. vial.....................................	AH and BD, BT, BW, CS	3	12
80 U. per cc................................	10 cc. vial...................................	AH and BD. BT. BW	3	12
100 U. per cc..............................	5 cc. vial.....................................	CS	3	12”;

(d) by omitting items 125, 126 and 127 and inserting in their stead the following items :—

“ 125	Penicillin, Injection of ...........	5,000 U ......................................	amp ...........................................	CS	6
15,000 U.....................................	amp............................................	CS	6
100,000 U...................................	amp............................................	AH, BD, BT, CS, EV, GL, IC, SI	6
200,000 U...................................	amp............................................	AH, BD, BT, CS, EV, GL, IC, SI	6

 

“ 125	Penicillin, Injection of—	500,000 U...................................	amp............................................	AH, BD, BT, CS, EV, GL, IC, SI	3
contd.	continued....................................
1,000,000 U................................	amp............................................	AH, BD, BT, CS, EV, GL, IC, SI	1
1,500,000 U................................	amp	GL	1
“ 126	Penicillin, Procaine, Aqueous Suspension of..........................	300,000 U...................................	amp............................................	BT	3
400,000 U.	vial ............................................	FA	3
600,000 U...................................	vial ............................................	BT	2
900,000 U...................................	vial ............................................	CS, DH, SI	2
1,000,000 U................................	vial ............................................	PA	1
1,500,000 U................................	vial ............................................	CS, GL, SI	1
“ 127	Penicillin, Procaine (Crystalline), Injection of.............................	300,000 U...................................	amp............................................	AH, BD, BT, BW, CS, DH, EV, IC, MB, SI	3
400,000 U...................................	amp............................................	AH, BD, BT, BW, CS, EV, GL, IC, MB, SI	3
500,000 U...................................	amp............................................	CS	3
600,000 U...................................	amp............................................	DH	2
667,000 U...................................	amp............................................	CS	2
900,000 U...................................	amp............................................	AH, BD, BT, BW, CS, EV, IC, MB, SI	2
1,200,000 U................................	amp............................................	AH, BD, BT, BW, CS, DH, EV, IC, MB, SI	1
1,500,000 U................................	amp............................................	CS, GL, SI	1
(e) by omitting item 141 and inserting in its stead the following item :—
“ 141	Phthalylsulphathiazole	0.5 G.....................................	tablet ....................................	MB, SD	100	. .”;
(f) by omitting item 153 and inserting in its stead the following item :—
“ 153	Pyridoxine Hydrochloride, Injection of............................................	50 mg. per cc.........................	1 cc. amp...............................	AN, BL, CM, DH, PM, KL, PD, RO	6	1
50 mg. per 2 cc......................	2 cc. amp...............................	BD, RO, VM	6	1
50 mg. per cc.........................	5 cc. vial ...............................	LY	1	1
50 mg. per cc.........................	10 co. vial.............................	KL	1	. .”
and

  

(g) by omitting item 183 and inserting in its stead the following item :—
“ 183	Theophylline with Ethylene Diamine.................................	0.366 G. per 10 mil................	10 mil. amp...........................	AB	6
0.732 G. per 2 mil..................		2 mil. amp.............................	AB	6
0.48 G. per 2 mil....................	2 mil. I.M. amp......................	DH, HA	6
0.5 G. per 2 mil......................	2 mil. I.M. amp......................	AH, BW, CM	6
0.24G. per 10 mil...................	10 mil. I.V. amp....................	DH. HA	6
0.25 G. per 10 mil..................	10 mil. I.V. amp....................	AH, BW, CM	6
l½gr.......................................	tablet ....................................	BT, BW, CM, DH, EA, HA, HY, KL, RT, SI, SM	100	1
2.34 gr...................................	tablet ....................................	AB	100	l”.

Second Schedule.

4. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting item 1 and inserting in its stead the following item :—

 

“ 1

Aureomycin.............................................

50 mg............

capsule .........

LE ........................................

25

Acute amoebic dysentery

100 mg..........

capsule .........

LE ........................................

25

Acute and sub-acute bacterial endocarditis-streptococcus faecalis

250 mg..........

capsule .........

LE ........................................

16

100 mg..........

Vial...............

LE ........................................

6

Staphylococcal infections that do not respond to penicillin

Pneumonia that has not responded to penicillin or to sulphonamides Psittacosis

Urinary tract infections due to streptococcus faecalis ”; and

(b) by omitting item 28 and inserting in its stead the following item :—

“ 28

Testosterone, Methyl..............................................

25 mg.....................

tablet .....................

AN, BD, BS, BT, CB, HY, KL, OR, SC

25

1

Mammary carcinoma Castration”.

50 mg.....................

tablet .....................

AN, BD, BS, BT, HY, KL, OR, SC

25

1

By Authority : L. F. Johnston, Commonwealth Government Printer, Canberra.